← All companies

RGNT

Regentis Biomaterials Ltd.

RGNT NYSE Orthopedic, Prosthetic & Surgical Appliances & Supplies EDGAR ↗

$1.87

+0.07 +3.89%

Key statistics

from XBRL data in SEC filings

Market cap

$9.69M

Revenue (TTM)

—

Net income (TTM)

-$13.6M

EPS (TTM)

$-24.16

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

$7.38M

Total assets

$7.62M

Gross margin

—

52-week range

$1.23 – $15.50

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K REPORT OF FOREIGN PRIVATE ISSUER Jul 20, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER Jul 15, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER Jul 9, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER Jul 2, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER Jun 18, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER Jun 15, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER Jun 8, 2026 6-K/A AMENDMENT NO. 1 TO FORM 6-K Jun 4, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER May 28, 2026 20-F/A AMENDMENT NO. 1 TO FORM 20-F Feb 27, 2026 20-F ANNUAL REPORT Feb 24, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER Feb 24, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER Feb 17, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER Feb 5, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER Jan 29, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER Jan 20, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER Jan 6, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER Jan 6, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER Dec 18, 2025 6-K REPORT OF FOREIGN PRIVATE ISSUER Dec 5, 2025

Other filings

EFFECT Jul 13, 2026 4 Jul 13, 2026 424B3 PROSPECTUS Jul 13, 2026 4 Jul 13, 2026 4 Jul 13, 2026 4 Jul 13, 2026 4 Jul 13, 2026 4 Jul 13, 2026 F-1 REGISTRATION STATEMENT Jul 8, 2026 D Item 06c Jun 25, 2026 RW WITHDRAWAL REQUEST Jun 15, 2026 F-1/A AMENDMENT NO. 1 TO FORM F-1 Jun 9, 2026 FWP FREE WRITING PROSPECTUS May 29, 2026 F-1 REGISTRATION STATEMENT May 1, 2026 3 Mar 30, 2026 3 Mar 18, 2026 3 Mar 18, 2026 3 Mar 18, 2026 3 Mar 18, 2026 3 Mar 18, 2026